JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/19.07.24 Share Price

Warrant

DE000JK8U306

Real-time Bid/Ask 05:28:34 27/06/2024 pm IST
0.39 EUR / 0.46 EUR +57.41% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/19.07.24
Current month-70.00%
1 month-61.97%
Date Price Change
27/24/27 0.38 +40.74%
25/24/25 0.27 +22.73%
24/24/24 0.22 -15.38%
21/24/21 0.26 -35.00%
20/24/20 0.4 -4.76%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 04:37 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JK8U30
ISINDE000JK8U306
Date issued 10/05/2024
Strike 225 $
Maturity 19/07/2024 (22 Days)
Parity 10 : 1
Emission price 0.39
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1
Lowest since issue 0.22
Delta-0.34x
Omega 17.11
Premium4.82x
Gearing50.94x
Moneyness 0.9714
Difference Strike -6.62 $
Difference Strike %-2.94%
Spread 0.07
Spread %15.22%
Theoretical value 0.4250
Implied Volatility 34.39 %
Total Loss Probability 63.33 %
Intrinsic value 0.000000
Present value 0.4250
Break even 220.45 €
Theta-0.11x
Vega0.02x
Rho-0x

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
231.6 USD
Average target price
279.2 USD
Spread / Average Target
+20.54%
Consensus